SC
CELG

Sculptor Capital’s Celgene Corp CELG Stock Holding History

Sculptor Capital’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-356,600
Closed -$39.9M – 893
2014
Q4 		$39.9M Hold
356,600
– – 0.11% 168
2014
Q3 		$33.8M Hold
356,600
– – 0.1% 189
2014
Q2 		$30.6M Hold
356,600
– – 0.09% 216
2014
Q1 		$24.9M Sell
356,600
-1,385,800
-80% -$110M 0.08% 229
2013
Q4 		$147M Buy
1,742,400
+200
+0% +$15.8K 0.38% 77
2013
Q3 		$134M Buy
1,742,200
+43,000
+3% +$3.01M 0.38% 72
2013
Q2 		$99.4M Buy
+1,699,200
New +$102M 0.31% 98

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Sculptor Capital's CELG Position: Q4 2019 in Review

Sculptor Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 3,315,508 shares — an estimated $329M sold.

Sculptor Capital first reported a position in CELG in Q1 2019 and held it in 3 quarters. The position peaked at $329M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Sculptor Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Sculptor Capital sold 3,315,508 Celgene Corp shares in Q4 2019, an estimated $329M.
  • Sculptor Capital first reported a position in Celgene Corp in Q1 2019 and held it in 3 quarters.
  • Sculptor Capital's Celgene Corp position peaked at $329M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Sculptor Capital's 13F filing for Q4 2019, filed 14 Feb 2020.